Ethosomes for Coenzyme Q10 Cutaneous Administration: From Design to 3D Skin Tissue Evaluation
- PMID: 32503293
- PMCID: PMC7346166
- DOI: 10.3390/antiox9060485
Ethosomes for Coenzyme Q10 Cutaneous Administration: From Design to 3D Skin Tissue Evaluation
Abstract
Ethosome represents a smart transdermal vehicle suitable for solubilization and cutaneous application of drugs. Coenzyme Q10 is an endogenous antioxidant whose supplementation can counteract many cutaneous disorders and pathologies. In this respect, the present study describes the production, characterization, and cutaneous protection of phosphatidylcholine based ethosomes as percutaneous delivery systems for coenzyme Q10. CoQ10 entrapment capacity in ethosomes was almost 100%, vesicles showed the typical 'fingerprint' structure, while mean diameters were around 270 nm, undergoing an 8% increase after 3 months from production. An ex-vivo study, conducted by transmission electron microscopy, could detect the uptake of ethosomes in human skin fibroblasts and the passage of the vesicles through 3D reconstituted human epidermis. Immunofluorescence analyses were carried on both on fibroblasts and 3D reconstituted human epidermis treated with ethosomes in the presence of H2O2 as oxidative stress challenger, evaluating 4-hydroxynonenal protein adducts which is as a reliable biomarker for oxidative damage. Notably, the pretreatment with CoQ10 loaded in ethosomes exerted a consistent protective effect against oxidative stress, in both models, fibroblasts and in reconstituted human epidermis respectively.
Keywords: H2O2; dermal administration; ethosome; penetration enhancers; reconstituted human epidermis; small angle X-ray scattering; ubiquinone.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Ethosomes and Transethosomes for Mangiferin Transdermal Delivery.Antioxidants (Basel). 2021 May 12;10(5):768. doi: 10.3390/antiox10050768. Antioxidants (Basel). 2021. PMID: 34066018 Free PMC article.
-
Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study.Int J Mol Sci. 2022 Dec 1;23(23):15112. doi: 10.3390/ijms232315112. Int J Mol Sci. 2022. PMID: 36499432 Free PMC article.
-
Design and Characterization of Ethosomes for Transdermal Delivery of Caffeic Acid.Pharmaceutics. 2020 Aug 6;12(8):740. doi: 10.3390/pharmaceutics12080740. Pharmaceutics. 2020. PMID: 32781717 Free PMC article.
-
Coenzyme Q10, a cutaneous antioxidant and energizer.Biofactors. 1999;9(2-4):371-8. doi: 10.1002/biof.5520090238. Biofactors. 1999. PMID: 10416055 Review.
-
Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization.J Liposome Res. 2023 Mar;33(1):34-52. doi: 10.1080/08982104.2022.2085742. Epub 2022 Jun 13. J Liposome Res. 2023. PMID: 35695714 Review.
Cited by
-
Ethosomes and Transethosomes for Mangiferin Transdermal Delivery.Antioxidants (Basel). 2021 May 12;10(5):768. doi: 10.3390/antiox10050768. Antioxidants (Basel). 2021. PMID: 34066018 Free PMC article.
-
New Mechanisms of Action of Natural Antioxidants in Health and Disease II.Antioxidants (Basel). 2021 Jul 27;10(8):1200. doi: 10.3390/antiox10081200. Antioxidants (Basel). 2021. PMID: 34439447 Free PMC article.
-
MMP-Sensitive Macrophage-Targeted Coenzyme Q10 Nanomedicine for Rheumatoid Arthritis Treatment.Mol Pharm. 2025 Sep 1;22(9):5638-5651. doi: 10.1021/acs.molpharmaceut.5c00742. Epub 2025 Aug 5. Mol Pharm. 2025. PMID: 40763217 Free PMC article.
-
Improving the anti-ageing activity of coenzyme Q10 through protransfersome-loaded emulgel.Sci Rep. 2022 Jan 18;12(1):906. doi: 10.1038/s41598-021-04708-4. Sci Rep. 2022. PMID: 35042910 Free PMC article.
-
"Plurethosome" as Vesicular System for Cutaneous Administration of Mangiferin: Formulative Study and 3D Skin Tissue Evaluation.Pharmaceutics. 2021 Jul 23;13(8):1124. doi: 10.3390/pharmaceutics13081124. Pharmaceutics. 2021. PMID: 34452085 Free PMC article.
References
LinkOut - more resources
Full Text Sources